Clinicians develop model to calculate patient risk for NAFLD decompensation

Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide and is associated with conditions such as obesity and metabolic syndrome, which can lead to diabetes, stroke, and heart disease. Although common, identifying people who could be at risk for NAFLD decompensation can be challenging for physicians. “We needed a way […]

Koo explores links between liver disease and diabetes

Nonalcoholic fatty liver disease (NAFLD) has increasingly become a concern for people with diabetes and the providers who care for them. NAFLD causes insulin resistance in the liver, which plays a large role in the development of the diabetes. Young Do Koo, PhD, Postdoctoral Research Scholar in the Abel Lab, received a three-year Postdoctoral Fellowship […]